Artivion AORT Vascular tissues — Deferred preservation costs

Similar metrics at other companies

LMATInventory And Other Deferred Costs

$70.82M—

PSNLInventory And Other Deferred Costs

$6.93M+40.8%

SPSCIncurred deferred costs

$21.51M-24.8%

INSWInternational Product Carriers — Vessels Deferred Dry Dock And Other Property

$931.48M+12.0%

KDAmortization Of Deferred Costs

$433M+5.1%

PAYCAmount of Deferred Costs Related to Long-term Contracts

$872.8M+7.8%

Questions, answered.

What is Artivion's vascular tissues — deferred preservation costs?

Artivion (AORT) reported vascular tissues — deferred preservation costs of $27.35M in Q4 2025.

How has Artivion's vascular tissues — deferred preservation costs changed year-over-year?

Artivion's vascular tissues — deferred preservation costs increased by 8.5% year-over-year, from $25.21M to $27.35M.

What does vascular tissues — deferred preservation costs mean?

This metric represents the capitalized costs associated with the preservation and processing of vascular tissue products that have not yet been recognized as cost of goods sold. It reflects the value of inventory held in a state of readiness for surgical application, accounting for the specialized storage and maintenance required for biological grafts. Monitoring this balance provides insight into the company's investment in biological inventory and the efficiency of its tissue processing supply chain.